Stellate Ganglion Block to Treat Long COVID 19 Case Series

Sponsor

Metamorphosis LTD (Other)

Overall Status

Completed

CT.gov ID

NCT05812209

Collaborator

(none)

Enrollment

Location

Actual Duration (Months)

10.3

Patients Per Site Per Month

Study Details

Study Description

Brief Summary

An assessment of the effectiveness of Stellate Ganglion Block in alleviating symptoms of Long COVID-19.

Condition or Disease	Intervention/Treatment	Phase
Long COVID Long Covid19 Post-COVID-19 Syndrome Post Acute COVID-19 Syndrome Dysautonomia Anosmia Dysgeusia Brain Fog Muscle Pain Shortness of Breath Dizziness Fatigue Post Viral Cough Menstrual Cycle Abnormal Pain	Procedure: Stellate Ganglion Block

Detailed Description

We evaluated the treatment results of 41 patients (18 male and 23 female) aged between 18 and 89, who received Stellate Ganglion Block (SGB) with Ultrasound guidance for Long COVID-19 Syndrome. The patients were from the United States and received treatment at our Colorado clinics during the period of September to December 2022.Those who responded to our post-procedure follow-up calls were included in the study population.

Study Design

Study Type:

Observational

Actual Enrollment :

41 participants

Observational Model:

Cohort

Time Perspective:

Retrospective

Official Title:

Stellate Ganglion Block to Treat Long COVID-19 Syndrome, A 41 Patient Retrospective Cohort Study

Actual Study Start Date :

Sep 1, 2022

Actual Primary Completion Date :

Dec 31, 2022

Actual Study Completion Date :

Dec 31, 2022

Arms and Interventions

Arm	Intervention/Treatment
SGB Patients for Long COVID 19 Patients who received ultrasound guided Stellate Ganglion block for symptoms of Long COVID in our Colorado clinics.	Procedure: Stellate Ganglion Block Ultrasound guided block of the Stellate Ganglion with local anesthetics. Other Names: SGB

Arm

Intervention/Treatment

SGB Patients for Long COVID 19

Patients who received ultrasound guided Stellate Ganglion block for symptoms of Long COVID in our Colorado clinics.

Procedure: Stellate Ganglion Block

Ultrasound guided block of the Stellate Ganglion with local anesthetics.

Other Names:

SGB

Outcome Measures

Primary Outcome Measures

Symptom Response [3 months]
Evaluation of the symptoms response to the Stellate Ganglion Block

Eligibility Criteria

Criteria

Ages Eligible for Study:

N/A and Older

Sexes Eligible for Study:

All

Accepts Healthy Volunteers:

Inclusion Criteria: People who scheduled themselves for a SGB in our clinics in Colorado.

Exclusion Criteria:

Stellate Ganglion Block Contraindications

Contacts and Locations

Locations

	Site	City	State	Country	Postal Code
1	Metamorphosis LTD	Cañon City	Colorado	United States	81212

Sponsors and Collaborators

Metamorphosis LTD

Investigators

Principal Investigator: Lisa Pearson, DNAP, Metamorphosis LTD

Study Documents (Full-Text)

None provided.

More Information

Publications

None provided.

Responsible Party:

Lisa Pearson, Dr. Lisa Pearson, CRNA, NSPMc, Metamorphosis LTD

ClinicalTrials.gov Identifier:

NCT05812209

Other Study ID Numbers:

SGBCOVID

First Posted:

Apr 13, 2023

Last Update Posted:

Apr 13, 2023

Last Verified:

Apr 1, 2023

Individual Participant Data (IPD) Sharing Statement:

Yes

Plan to Share IPD:

Yes

Studies a U.S. FDA-regulated Drug Product:

Studies a U.S. FDA-regulated Device Product:

Additional relevant MeSH terms:

Primary Dysautonomias

Autonomic Nervous System Diseases

Dysgeusia

Syndrome

Dizziness

Study Results

No Results Posted as of Apr 13, 2023